Colleen Tucker

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Colleen Tucker worked as a Senior Director of Human Resources at Momenta Pharmaceuticals, Inc. She then worked as the Head of Human Resources at Entasis Therapeutics Holdings, Inc. from 2020 to 2021.
Tucker received her undergraduate degree from Providence College and her graduate degree from Lesley University.

Precedenti posizioni note di Colleen Tucker

Società	Posizione	Fine
ENTASIS THERAPEUTICS HOLDINGS INC.	Ufficiale delle Risorse Umane	01/11/2021
MOMENTA PHARMACEUTICALS, INC.	Ufficiale delle Risorse Umane	-

Vedi nel dettaglio l'esperienza di Colleen Tucker

Formazione di Colleen Tucker

Providence College	Undergraduate Degree
Lesley University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Colleen Tucker

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Entasis Therapeutics Holdings, Inc. Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA.	Health Technology
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology